Skip to main content

Advertisement

SpringerLink
Log in

Association between the G870A polymorphism of Cyclin D1 gene and glioma risk

  • Research Article
  • Published:
Tumor Biology

Abstract

Previous studies have shown the association of the Cyclin D1 (CCND1) G870A polymorphism with glioma risk, but the findings are inconsistent and inconclusive. To shed some light on the findings across individual studies and acquire a quantitative assessment of this association, we conducted a meta-analysis of all published case–control studies thus far. Four independent studies with a total of 690 cases and 1,014 controls were identified after a systematic search of the PubMed, Embase, Web of Science, and Wanfang databases. The strength of the association between the CCND1 G870A polymorphism and glioma risk was estimated by the pooled odds ratios (ORs) with 95 % confidence intervals (95 %CIs). Subgroup analysis by ethnicity was also performed. Overall, a statistically significant association was found between the CCND1 G870A polymorphism and glioma risk in three genetic models (ORA vs. G = 1.178, 95 %CI 1.025–1.354, P OR = 0.021; ORAA vs. GG = 1.328, 95 %CI 1.007–1.750, P OR = 0.045; ORAA + AG vs. GG = 1.253, 95 %CI 1.006–1.516, P OR = 0.044). In subgroup analysis, the pooled ORs suggested that the CCND1 G870A polymorphism was associated with an increased risk of glioma in Caucasians under the heterozygote and dominant genetic models (ORAG vs. GG = 1.329, 95 %CI 1.001–1.766, P OR = 0.049; ORAA + AG vs. GG = 1.332, 95 %CI 1.019–1.740, P OR = 0.036). The meta-analysis suggests that the CCND1 G870A polymorphism is a risk factor for the development of glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.

    Article  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  3. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomark Prev. 2000;9(8):843–7.

    CAS  Google Scholar 

  4. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278–99.

    PubMed Central  PubMed  Google Scholar 

  5. Bedewy AM, Mostafa MH, Saad AA, El-Maghraby SM, Bedewy MM, Hilal AM, et al. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer. J BUON. 2013;18(1):227–38.

    CAS  PubMed  Google Scholar 

  6. Cakina S, Gulyasar T, Ozen A, Sipahi T, Kocak Z, Sener S. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer. Indian J Biochem Biophys. 2013;50(3):233–6.

    CAS  PubMed  Google Scholar 

  7. Li J, Luo F, Zhang H, Li L, Xu Y. The CCND1G870A polymorphism and susceptibility to bladder cancer. Tumour Biol. 2014;35(1):171–7.

  8. Sameer AS, Parray FQ, Dar MA, Nissar S, Banday MZ, Rasool S, et al. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study. Mol Med Rep. 2013;7(3):811–5.

    CAS  PubMed  Google Scholar 

  9. Zeybek U, Yaylim I, Ozkan NE, Korkmaz G, Turan S, Kafadar D, et al. Cyclin D1 gene G870A variants and primary brain tumors. APJCP. 2013;14(7):4101–6.

    PubMed  Google Scholar 

  10. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;25(11):1620–8.

    Article  CAS  PubMed  Google Scholar 

  11. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization RB phosphorylation and cellular transformation. J Biol Chem. 2003;278(32):30339–47.

    Article  CAS  PubMed  Google Scholar 

  12. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2773–81.

    Article  CAS  PubMed  Google Scholar 

  13. Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, et al. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res. 2009;15(17):5338–49.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995;11(5):1005–11.

    CAS  PubMed  Google Scholar 

  15. Weinstein IB, Begemann M, Zhou P, Han EK, Sgambato A, Doki Y, et al. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res: Off J Am Assoc Cancer Res. 1997;3(12 Pt 2):2696–702.

    CAS  Google Scholar 

  16. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 1998;16(13):1701–12.

    Article  CAS  PubMed  Google Scholar 

  17. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, et al. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer. 2006;94(6):928–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37(3–4):256–66.

    Article  CAS  PubMed  Google Scholar 

  19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  22. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316(7129):469–77.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1655–61.

    Article  CAS  PubMed  Google Scholar 

  25. Chen X, Zhao T, Li L, Xu C, Zhang X, Tse V, et al. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. DNA Cell Biol. 2012;31(6):1107–13.

    Article  CAS  PubMed  Google Scholar 

  26. Fan PL, Liu XQ. The cyclin D1 A870G polymorphism susceptibility with glioma. Harbin: Harbin Medical University; 2010 [Article in Chinese].

    Google Scholar 

  27. Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT, et al. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology. 2007;29(1–2):55–8.

    Article  PubMed  Google Scholar 

  28. Yang P, Kollmeyer TM, Buckner K, Bamlet W, Ballman KV, Jenkins RB. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer. 2005;103(11):2363–72.

    Article  CAS  PubMed  Google Scholar 

  29. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurother: J Am Soc Exp Neuro Ther. 2009;6(3):427–35.

    Article  CAS  Google Scholar 

  30. Holland EC. Glioma genesis: genetic alterations and mouse models. Nat Rev Genet. 2001;2(2):120–9.

    Article  CAS  PubMed  Google Scholar 

  31. Li Y, Zhao Y, Liu J, Liu P, Xu Y. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population. Genet Test Mol Biomarkers. 2012;16(5):449–52.

    Article  CAS  PubMed  Google Scholar 

  32. Sherr CJ. D-type cyclins. Trends Biochem. 1995;20(5):187–90.

    Article  CAS  Google Scholar 

  33. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes. 2004;18(22):2699–711.

    Article  CAS  Google Scholar 

  34. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 2008;112(11):2467–74.

    Article  CAS  PubMed  Google Scholar 

  35. Buch S, Zhu B, Davis AG, Odom D, Siegfried JM, Grandis JR, et al. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract. Mol Carcinog. 2005;42(4):222–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Affiliated Xuzhou Hospital of Southeast University, Xuzhou, Jiangsu, 221009, China

    Hailiang Zong, Lei Cao, Chong Ma, Jianping Zhao, Xing Ming, Ming Shang & Hongsheng Xu

Authors
  1. Hailiang Zong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xing Ming
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ming Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hongsheng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hongsheng Xu.

Additional information

Hailiang Zong and Lei Cao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zong, H., Cao, L., Ma, C. et al. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk. Tumor Biol. 35, 8095–8101 (2014). https://doi.org/10.1007/s13277-014-1981-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1981-2

Keywords

Search

Navigation